ALK and anaplastic large cell lymphoma: Thus, miRNAs influence the cellular phenotype and pathogenesis of NPM-ALK+ ALCL and are emerging as tissue-specific biomarkers with potential clinical applications for both identifying cancer subtypes and developing new therapies (132–134).